Literature DB >> 17286550

New advances in the rehabilitation of CNS diseases applying rTMS.

Judit Málly1, Trevor W Stone.   

Abstract

Transcranial magnetic stimulation (TMS) can directly stimulate the CNS, modifying the brain's plasticity to enhance the behavior of the paretic extremities. Studies with low-frequency repetitive TMS (rTMS) on the intact hemisphere and those with high frequencies on the affected hemisphere could increase the speed of movement in the hand affected by CNS injury. Stimulation of the motor pathway may contribute to faster improvement in patients with spinal cord injury. Symptoms of Parkinson's disease (such as cognition and working memory, neglect syndrome and global aphasia) can be influenced by rTMS. However, the site of stimulation and the parameters of rTMS are different. Processes that contribute to the behavior of rTMS include the modification of brain plasticity, induction of neurogenesis, growth of new fibers in the spinal cord or all of these together. According to previous research, rTMS may be suitable as an add-on therapy to rehabilitation in CNS diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17286550     DOI: 10.1586/14737175.7.2.165

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

1.  Effects of rTMS on Parkinson's disease: a longitudinal fMRI study.

Authors:  Nadia González-García; Jorge L Armony; Julian Soto; David Trejo; Marco A Alegría; René Drucker-Colín
Journal:  J Neurol       Date:  2011-02-05       Impact factor: 4.849

Review 2.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

3.  Electromagnetic field stimulation potentiates endogenous myelin repair by recruiting subventricular neural stem cells in an experimental model of white matter demyelination.

Authors:  Mohammad Amin Sherafat; Motahareh Heibatollahi; Somayeh Mongabadi; Fatemeh Moradi; Mohammad Javan; Abolhassan Ahmadiani
Journal:  J Mol Neurosci       Date:  2012-05-17       Impact factor: 3.444

4.  Transcranial magnetic stimulation with the maximum voluntary muscle contraction facilitates motor neuron excitability and muscle force.

Authors:  Tetsuo Touge; Yoshiteru Urai; Kazuyo Ikeda; Kodai Kume; Kazushi Deguchi
Journal:  Neurol Res Int       Date:  2012-03-20

5.  Basic mechanisms of rTMS: Implications in Parkinson's disease.

Authors:  Oscar Arias-Carrión
Journal:  Int Arch Med       Date:  2008-04-15

6.  The Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice.

Authors:  Qiaoyun Dong; Yanyong Wang; Ping Gu; Rusheng Shao; Li Zhao; Xiqi Liu; Zhanqiang Wang; Mingwei Wang
Journal:  Parkinsons Dis       Date:  2015-03-25

7.  The effect of computer-assisted cognitive rehabilitation and repetitive transcranial magnetic stimulation on cognitive function for stroke patients.

Authors:  In-Seok Park; Jung-Gyu Yoon
Journal:  J Phys Ther Sci       Date:  2015-03-31

8.  Repetitive Transcranial Magnetic Stimulation Ameliorates Cognitive Impairment by Enhancing Neurogenesis and Suppressing Apoptosis in the Hippocampus in Rats with Ischemic Stroke.

Authors:  Feng Guo; Jicheng Lou; Xiaohua Han; Yuguo Deng; Xiaolin Huang
Journal:  Front Physiol       Date:  2017-08-02       Impact factor: 4.566

Review 9.  Real-Time Artifacts Reduction during TMS-EEG Co-Registration: A Comprehensive Review on Technologies and Procedures.

Authors:  Giuseppe Varone; Zain Hussain; Zakariya Sheikh; Adam Howard; Wadii Boulila; Mufti Mahmud; Newton Howard; Francesco Carlo Morabito; Amir Hussain
Journal:  Sensors (Basel)       Date:  2021-01-18       Impact factor: 3.576

10.  Repetitive transcranial magnetic stimulation promotes neural stem cell proliferation via the regulation of MiR-25 in a rat model of focal cerebral ischemia.

Authors:  Feng Guo; Xiaohua Han; Jinghui Zhang; Xiuxiu Zhao; Jicheng Lou; Hong Chen; Xiaolin Huang
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.